Prix JBM (Healthcare) Limited (02161.HK)

JBM (Healthcare) Ltd. is an investment holding company, which engages in the development, manufacturing, sourcing, distribution, and marketing of branded healthcare products. The company employs 412 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Branded Medicines segment is engaged in the development, manufacture and distribution of branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment is engaged in the development, manufacture and distribution of registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal or mineral origin customarily or widely used by the Chinese. The Health and Wellness Products segment is engaged in the distribution and sale of supplements, medical consumables and other nonpharmaceutical products for the general health and wellness of consumers.